Submissions from 2019
Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases, Rupesh Kotecha
Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiotherapy for localized prostate cancer, Rupesh Kotecha
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Low-Grade Glioma Radiotherapy Treatment and Trials, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2018
Combining immunotherapy with radiation therapy in thoracic oncology, Michael Chuong
Full Text Restricted – Available from BHSF IP or login only
Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres, Michael Chuong
Full Text Restricted – Available from BHSF IP or login only
Mid/Distal Esophageal Cancer and Gastroesophageal Junction Cancer (Siewert Type I and II), Michael Chuong
Full Text Restricted – Available from BHSF IP or login only
Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial, Michael Chuong
Full Text Restricted – Available from BHSF IP or login only
Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer, Michael Chuong, Man Yam, and Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Proton beam therapy for gastrointestinal cancers: past, present, and future, Matthew Hall and Michael Chuong
Full Text Restricted – Available from BHSF IP or login only
Early Objective Response as a Prognosticator for Final Objective Response and Survival following SRS for Brain Metastases Treated with Concurrent Systemic Therapy, Rupesh Kotecha
Full Text Restricted – Available from BHSF IP or login only
Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma, Rupesh Kotecha
Full Text Restricted – Available from BHSF IP or login only
Proton therapy patterns of care among pediatric and adult patients with CNS tumors, Rupesh Kotecha
Full Text Restricted – Available from BHSF IP or login only
Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing, Rupesh Kotecha
Full Text Restricted – Available from BHSF IP or login only
Ten-Year Outcomes and Toxicity with Moderately Hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer, Rupesh Kotecha
Full Text Restricted – Available from BHSF IP or login only
Recent advances in managing brain metastasis, Rupesh Kotecha and Minesh Mehta
Open Access
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Brain Metastases in Lung Cancer With Targetable Mutations-Reply, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Control versus cognition: the changing paradigm of adjuvant therapy for resected brain metastasis, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539, Minesh Mehta
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Short delay in initiation of radiotherapy for patients with glioblastoma- effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells, Minesh Mehta
Open Access
The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
What is the evidence for the clinical value of SBRT in cancer of the cervix?, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?, Minesh Mehta and Rupesh Kotecha
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2017
Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529, Andre Abitbol
Full Text Restricted – Available from BHSF IP or login only
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee, Michael Chuong
Full Text Restricted – Available from BHSF IP or login only
The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings, Michael Chuong
Full Text Restricted – Available from BHSF IP or login only
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients, Michael Chuong and Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA), Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
State of the art: the evolving role of RT in combined modality therapy for GBM, Minesh Mehta
The Changing Role of Whole-Brain Radiotherapy: Demise or Time for Selective Usage?, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
The role of radiation in treating glioblastoma: here to stay, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer, Minesh Mehta and Michael Chuong
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2016
HPV-Associated Oropharyngeal Cancer: Changing Treatment Paradigm & Prognosis, Andre Abitbol
An overview of modern proton therapy, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Clinical ramifications of "genomic staging" of low-grade gliomas, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
International Medical Graduates in Radiation Oncology: Historical Trends and Comparison With Other Medical Specialties, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Reply to M.C. Chamberlain, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Stereotactic Radiosurgery for Treatment of Brain Metastases, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2014
Predictors of radiotherapy-related GI toxicity from anal cancer DP-IMRT: Secondary analysis of RTOG 0529, Andre Abitbol
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2012
Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer, Alan Lewin, Robert Derhagopian, Andre Abitbol, D Jay Wieczorek, Vivek Mishra, and Lourdes Moreno
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2007
Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife, William Brown, Alan Lewin, and Andre Abitbol
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2005
Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol, Andre Abitbol, Alan Lewin, and Michael Troner
Full Text Restricted – Available from BHSF IP or login only
Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma, Andre Abitbol, Alan Lewin, and Michael Troner
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2002
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol, Andre Abitbol, Alan Lewin, Michael Troner, and Maria-Amelia Rodrigues
Full Text Restricted – Available from BHSF IP or login only
Submissions from 1996
Management of stage I-B, II-A, and II-B carcinoma of the cervix with high-dose-rate brachytherapy: initial results of an institutional clinical trial, Andre Abitbol and Alan Lewin
Full Text Restricted – Available from BHSF IP or login only
Submissions from 1993
Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumors. Clinical Research Committee, American Endocurietherapy Society, Andre Abitbol
Full Text Restricted – Available from BHSF IP or login only
Submissions from 1992
Stereotactic radiosurgery: dose-volume analysis of linear accelerator techniques, Christopher Serago, Alan Lewin, Andre Abitbol, Sergio Gonzalez-Arias, and Victor Marcial-Vega
Full Text Restricted – Available from BHSF IP or login only
Submissions from 1991
Scattering effects on the dosimetry of iridium-192, Christopher Serago, Andre Abitbol, Alan Lewin, and Victor Marcial-Vega
Full Text Restricted – Available from BHSF IP or login only
Stereotactic target point verification of an X ray and CT localizer, Christopher Serago, Alan Lewin, Sergio Gonzalez-Arias, and Andre Abitbol
Full Text Restricted – Available from BHSF IP or login only
Improved linac dose distributions for radiosurgery with elliptically shaped fields, Christopher Serago, Alan Lewin, Sergio Gonzalez-Arias, Andre Abitbol, and Victor Marcial-Vega
Full Text Restricted – Available from BHSF IP or login only